Evidence map›Paper›PMID 37125552›Full record

ArticleJournal of Alzheimer's disease : JAD2023

Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.

Laura E Gibbons, Melinda C Power, Rod L Walker, Raj G Kumar, Alia Murphy, Caitlin S Latimer, Amber L Nolan, Erica J Melief, Allison Beller, Marika Bogdani and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Irisin Restrains Oligodendroglial Ferroptosis to Preserve White Matter After Traumatic Brain Injury via AMPK Activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Heliyon · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Laura E GibbonsGeneral Internal Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Melinda C PowerGeorge Washington University Milken Institute School of Public Health, Washington, DC, USA.
Rod L WalkerKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Raj G KumarDepartment of Rehabilitation and Human Performance, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alia MurphyGeorge Washington University Milken Institute School of Public Health, Washington, DC, USA.
Caitlin S LatimerDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Amber L NolanDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Erica J MeliefDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Allison BellerDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Marika BogdaniDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
C Dirk KeeneDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Eric B LarsonGeneral Internal Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Paul K CraneGeneral Internal Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Kristen Dams-O'ConnorDepartment of Rehabilitation and Human Performance, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
University of Washington · USIcahn School of Medicine at Mount Sinai · USGeorge Washington University · USKaiser Permanente Washington Health Research Institute · USMilken Institute · US

Funding

Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergicsU19AG066567 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Pamela A Shaw · 2021 to 2026
$80.4M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Lynn Bekris · 2020 to 2026
$29.0M
The Late Effects of TBI (LETBI) Study: Injury Patterns and Biological Markers of Post-Traumatic NeurodegenerationRF1NS115268 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Kristen Dams-O'Connor · 2019 to 2026
$10.3M
Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo DiagnosticsU01NS086625 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN · 2014 to 2017
$6.1M
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)R01AG061028 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN, MEZ, JESSE BENJAMIN · 2019 to 2023
$5.9M
Cortical Somatostatin Interneuron Dysfunction after Trauma: Role in Cognitive FlexibilityK08NS114170 · NINDS · UNIVERSITY OF WASHINGTON · PI NOLAN, AMBER L · 2019 to 2023
$1.0M
NIA NIH HHS P30 AG066509NIA NIH HHS P50 AG005136NIA NIH HHS R01 AG061028NIA NIH HHS U01 AG006781NIA NIH HHS U19 AG066567NINDS NIH HHS K08 NS114170NINDS NIH HHS RF1 NS115268NINDS NIH HHS U01 NS086625
6 · The paper itself

Abstract

backgroundPrior studies into the association of head trauma with neuropathology have been limited by incomplete lifetime neurotrauma exposure characterization.

objectiveTo investigate the neuropathological sequelae of traumatic brain injury (TBI) in an autopsy sample using three sources of TBI ascertainment, weighting findings to reflect associations in the larger, community-based cohort.

methodsSelf-reported head trauma with loss of consciousness (LOC) exposure was collected in biennial clinic visits from 780 older adults from the Adult Changes in Thought study who later died and donated their brain for research. Self-report data were supplemented with medical record abstraction, and, for 244 people, structured interviews on lifetime head trauma. Neuropathology outcomes included Braak stage, CERAD neuritic plaque density, Lewy body distribution, vascular pathology, hippocampal sclerosis, and cerebral/cortical atrophy. Exposures were TBI with or without LOC. Modified Poisson regressions adjusting for age, sex, education, and APOE ɛ4 genotype were weighted back to the full cohort of 5,546 participants.

resultsTBI with LOC was associated with the presence of cerebral cortical atrophy (Relative Risk 1.22, 95% CI 1.02, 1.42). None of the other outcomes was associated with TBI with or without LOC.

conclusionTBI with LOC was associated with increased risk of cerebral cortical atrophy. Despite our enhanced TBI ascertainment, we found no association with the Alzheimer's disease-related neuropathologic outcomes among people who survived to at least age 65 without dementia. This suggests the pathophysiological processes underlying post-traumatic neurodegeneration are distinct from the hallmark pathologies of Alzheimer's disease.

Indexed as

Alzheimer DiseaseBrain Injuries, TraumaticAgedBrainDeathHumansUnconsciousnessAlzheimer’s diseaseatrophydementianeuropathologytraumatic brain injury

Identifiers

PMID37125552
PMCPMC10860614
OpenAlexW4367310474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.